Panel Sequencing for Clinically Oriented Variant Screening and Copy Number Detection in Chronic Lymphocytic Leukemia Patients

According to current guidelines, in chronic lymphocytic leukemia (CLL), only the TP53 molecular status must be evaluated prior to every treatment’s initiation. However, additional heterogeneous genetic events are known to confer a proliferative advantage to the tumor clone and are associated with pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibáñez, Mariam, Such, Esperanza, Liquori, Alessandro, Avestisyan, Gayane, Andreu, Rafael, Vicente, Ana, Macián, María José, Melendez, Mari Carmen, Morote-Faubel, Mireya, Asensi, Pedro, Lloret, María Pilar, Jarque, Isidro, Picón, Isabel, Pacios, Alejandro, Donato, Eva, Mas-Ochoa, Carmen, Alonso, Carmen, Cañigral, Carolina, Sempere, Amparo, Romero, Samuel, Santiago, Marta, Sanz, Guillermo F., de la Rubia, Javier, Senent, Leonor, Luna, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031851/
https://www.ncbi.nlm.nih.gov/pubmed/35454001
http://dx.doi.org/10.3390/diagnostics12040953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031851/
https://www.ncbi.nlm.nih.gov/pubmed/35454001
http://dx.doi.org/10.3390/diagnostics12040953

Ejemplares similares